(3BL Media / theCSRfeed) NOVO ALLE, Denmark - December 1, 2011 - As of 28 November 2011, Novo Nordisk will no longer use living animals to test the quality of the batches of medicine coming out of Novo Nordisk’s production lines. These tests have for years been required by health authorities as part of their approval of the products. <br /><br />“Today’s achievement is a milestone in our ongoing commitment to animal ethics in Novo Nordisk. We have been working for more than a decade, in close collaboration with regulatory authorities around the world, to eliminate obsolete tests or develop and certify new laboratory assays that can be used instead of animals to evaluate the consistent quality of our marketed products,” says Executive Vice President and Chief Science Officer, Mads Krogsgaard Thomsen. <br /><br />Novo Nordisk has a commitment to the 3R principles to 'Reduce', 'Refine' or 'Replace' the use of animal testing within the pharmaceutical industry. Therefore, a task force was establi
